Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04702880
Title A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | ESP | CAN | BEL | AUS

Facility Status City State Zip Country Details
Local Institution - 0075 Birmingham Alabama 35233 United States Details
Local Institution - 0022 Hackensack New Jersey 07601 United States Details
Local Institution - 0002 Durham North Carolina 27710 United States Details
Local Institution - 0060 Cincinnati Ohio 45219 United States Details
Local Institution Cincinnati Ohio 45267 United States Details
Local Institution - 0067 Cleveland Ohio 44106-1716 United States Details
Local Institution - 0081 Nashville Tennessee 37203 United States Details
Local Institution Dallas Texas 75390 United States Details
Local Institution - 0003 Westmead New South Wales 2145 Australia Details
Local Institution - 0023 Greenslopes Queensland 4120 Australia Details
Local Institution - 0001 Malvern Victoria 3144 Australia Details
Local Institution - 0004 Murdoch Western Australia 6150 Australia Details
Local Institution - 0051 Charleroi 6000 Belgium Details
Local Institution - 0034 Gent 9000 Belgium Details
Local Institution - 0050 Liège 4000 Belgium Details
Local Institution - 0012 Edmonton Alberta T6G 1Z2 Canada Details
Local Institution - 0064 Brampton Ontario L6R 3J7 Canada Details
Local Institution - 0045 Heraklion Irakleío 715 00 Greece Details
Local Institution - 0036 Athens 11527 Greece Details
Local Institution - 0038 Athens 185 47 Greece Details
Local Institution - 0030 Peschiera del Garda 37019 Italy Details
Local Institution - 0031 Pisa 56124 Italy Details
Local Institution - 0029 Rozzano 20089 Italy Details
Local Institution - 0073 Sendai Miyagi 980-0873 Japan Details
Local Institution - 0070 Osaka-Sayama City Osaka 589-8511 Japan Details
Local Institution - 0069 Takatsuki Osaka 5698686 Japan Details
Local Institution - 0077 Ina-machi Saitama 362-0806 Japan Details
Local Institution - 0039 Amsterdam Noord-Holland 1081 HV Netherlands Details
Local Institution - 0066 Arnhem 6815 AD Netherlands Details
Local Institution - 0040 Groningen 9700RB Netherlands Details
Local Institution - 0049 Gdansk 80-214 Poland Details
Local Institution - 0048 Łódź 93-338 Poland Details
Local Institution - 0043 Bucharest 022328 Romania Details
Local Institution - 0042 Cluj 400015 Romania Details
Local Institution - 0041 Craiova 200542 Romania Details
Local Institution - 0007 Barcelona Barcelona [Barcelona] 08035 Spain Details
Local Institution - 0021 Madrid 28041 Spain Details
Local Institution - 0005 Majadahonda 28222 Spain Details
Local Institution - 0006 Málaga 29010 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field